About DBIS   | Story archive   | Contact DBIS  | DBIS home

First New Treatment for Lupus in 50 Years!

Rheumatologists Find Experimental Drug for Lupus Keeps Antibodies at Bay

January 1, 2010

Rheumatologists are using an experimental drug to treat Lupus by dampening the response of the immune system. It works by restraining the activity of the naturally occurring protein, BLYS, believed to be responsible for elevated levels of antibodies in diseases like Lupus. In such autoimmune diseases, antibodies attack and destroy healthy tissues. The drug binds to BLYS and prevents the antibodies from producing.

read the full story...

Science Insider

ABOUT LUPUS: Lupus is a chronic autoimmune disease that causes the immune system to attack the body's own tissue and organs, which may include the joints, kidneys, heart, lungs, brain, blood and skin. In an autoimmune disease, the body's immune system loses its ability to distinguish between foreign substances and its own cells and tissue. However, it is not infectious, or cancerous, and it is not associated with AIDS.

The mildest form of lupus consists of a red rash or change in skin color on the face, often in the shape of a butterfly across the nose and cheeks. Systemic lupus is more severe, accounting for 70 percent of all cases, in which inflammation in various tissues in the body occurs. This often leads to long-term damage to major organs, such as the lungs, kidneys, heart or brain. Symptoms include painful or swollen joints, frequent high fever, chest pain, swollen glands, fatigue, hair loss, pale or purple fingers or toes from cold or stress, sensitivity to the sun, low blood count, mouth sores, and unexplained seizures or kidney problems.

Scientists don't yet know what causes lupus, but they believe there is a genetic predisposition to the disease, compounded by environmental factors. Lupus may be triggered by infections, antibiotics, ultraviolet light, extreme stress, certain drugs and hormones. The latter might explain why lupus occurs more frequently in women than in men. Men are more likely to develop drug-induced lupus, triggered by drugs used to treat heart conditions more common in men.

The American Association of Pharmaceutical Scientists contributed to the information contained in the TV portion of this report.

Video help

Latest stories

  • Basketball: Bias Refs?
  • Can You Hear Me Now?
  • Car Parts Made Out of Coconuts
  • Fishy Cure for Hearing Loss: Medicine's Next Big Thing?
  • Garden Greener

More information on this story

New Lupus Drug

To Go Inside This Science:
Dan Page
Vice President, National Health Media Relations
Edelman
New York, NY 10013
513‑528‑0175 (office)
Dan.Page@edelman.com

American Association of Pharmaceutical Scientists
Joseph Catapano
Communications Specialist
catapanoj@aaps.org
703-248-4772


© 2010 American Institute of Physics